The Sun Pharmaceutical Industries has secured approval from the U.S. Food and Drug Administration (FDA) for an expanded label for its immunotherapy drug UNLOXCYT (cosibelimab ipdl). The updated label authorizes UNLOXCYT for use in adults with...
AstraZeneca’s Imfinzi has received US approval today for use with FLOT chemotherapy in adults with resectable, early-stage and locally advanced gastric and gastroesophageal junction (GEJ) cancers. The regimen includes Imfinzi before surgery...
Abbott has announced a medical device correction for select FreeStyle Libre 3 and FreeStyle Libre 3 Plus sensors in the U.S., after internal testing revealed that some units may deliver incorrect low glucose readings.The company says this flaw...
Dr. Shashank Teotia, CHRO, Paras Health, is a strategic human capital leader with over 22 years of experience across healthcare, edtech, ecommerce, insurance, FMCG and retail. He specialises in organisation design, culture building and leadership
Shilpa Medicare, Eight Observations, Unit IV, Jadcherla Telangana, Ten-Day Inspection, Sterile Injectables, Oral Tablets, Capsule Production, Regulatory Approvals, US Sales, Key Agencies, Consolidated Profit
The Central Drugs Standard Control Organisation (CDSCO) has informed procurement agencies, including hospitals, that a license from Indian licensing authorities must be obligatory for acquiring devices, with additional certifications required beyond
Roche has received conditional marketing approval in Europe for Lunsumio, a new subcutaneous form of its bispecific antibody that can be administered in a quick, one?minute injection. This approval marks one of the significant changes in the...
Tesaro, Inc., a GSK subsidiary, announces that it has filed a lawsuit against AnaptysBio, Inc. in the Delaware Chancery Court. This action asserts that recent behavior of AnaptysBio significantly violates the current licensing agreement with Tesaro
Ramaiah Memorial Hospital and Ramaiah Medical College became the center of global medical innovation with the inauguration of the Worldwide Network for Blood and Marrow Transplantation (WBMT) Symposium on Cell Therapy
Actimed Therapeutics today announced a licensing agreement with Mankind Pharma, giving the company exclusive rights to develop and commercialise Actimed’s products for the treatment and prevention of cachexia across India and several South Asian...
.jpg)
.jpg)
, CDSCO.jpg)